Steven Mnuchin Says He Is Putting Together a Group to Buy TikTok

The former Treasury Secretary's comments come after House voted to ban the app in the U.S. or force a sale. 


 
Meta to Replace Widely Used Data Tool-and Largely Cut Off Reporter Access

CrowdTangle has been a source for some embarrassing articles about its Facebook and Instagram. The company says its replacement tool is only for academics and nonprofit researchers. 


 
Dollar General Earnings Beat Estimates as Store Traffic Rises

The discount retailer posted fourth-quarter earnings of $1.83 a share on revenue of $9.86 billion. 


 
Another Top Credit Suisse Executive Leaves as UBS Integration Takes Hold

Global head of private funds David Klein has moved to TWG, a holding company that manages the investments of Los Angeles Dodgers co-owner Mark Walter. 


 
Dick's Sporting Goods Stock Rises After Earnings. Its Dividend Boost Is Only One Reason.

The sporting goods retailer tops quarterly earnings and sales estimates. 


 
Hilton Bets on College Towns With $210 Million Deal

The lodging giant is acquiring Graduate Hotels, a brand with properties near dozens of college campuses throughout the U.S. 


 
Under Armour's Kevin Plank to Take Back CEO Role

Plank served as CEO of Under Armour from 1996 to 2019, and was named executive chair and brand chief early in 2020. 


 
Hyundai Motor, Kia to Recall 170,000 EVs in South Korea

Hyundai Motor and sibling company Kia will recall around 170,000 electric vehicles in South Korea for faulty software that could cause a power loss while driving. 


 
WuXi Shares Fall as Washington Lobbying Group Cuts Ties

WuXi AppTec and its affiliates are taking another beating after the loss of support from the biotech industry's top lobbying group in Washington, as two bills targeting Chinese biotech companies wind their way through Congress. 


 
China Healthcare Stocks Rally on Hopes for Govt Support

Chinese pharmaceutical stocks rose sharply on hopes for government support, with analysts citing an alleged draft proposal on drug innovation widely circulated online and on social media.


(END) Dow Jones Newswires

03-14-24 0915ET